![](/img/cover-not-exists.png)
A Phase II trial of oral capecitabine in patients with platinum – and taxane – refractory ovarian, fallopian tube, or peritoneal cancer
Judith K. Wolf, Diane C. Bodurka, Claire Verschraegen, Charlotte C. Sun, Donna Branham, Alfred D. Jenkins, Neely Atkinson, David M. GershensonVolume:
102
Year:
2006
Language:
english
Pages:
7
DOI:
10.1016/j.ygyno.2005.12.040
File:
PDF, 167 KB
english, 2006